کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3945359 1254262 2011 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی زنان، زایمان و بهداشت زنان
پیش نمایش صفحه اول مقاله
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
چکیده انگلیسی

ObjectivesUterine carcinosarcoma (CS) is a rare but aggressive malignancy frequently associated with extrauterine metastasis at the time of diagnosis. The objective of this study was to assess the role of cytoreductive surgery in patients with stage IIIC–IVB uterine CS.MethodsWe conducted a retrospective review of all patients with uterine CS treated at our institution from 1990 to 2009. Clinicopathologic factors, surgical procedures, adjuvant therapy, and survival outcomes were collected for all patients. Progression-free survival (PFS) and overall survival (OS) were calculated using the Kaplan–Meier method. Factors predictive of survival outcomes were compared using the log-rank test and Cox regression analysis.ResultsAn analysis of 44 patients was performed (stage IIIC, n = 14; stage IVB, n = 30). Complete gross resection was achieved in 57% of patients. PFS and OS for the entire cohort were 8.6 months and 18.5 months, respectively. Complete gross resection was associated with a median OS of 52.3 months versus 8.6 months in patients with gross residual disease (P < 0.0001). Stage IIIC disease was associated with a median OS of 52.3 months versus 17.5 months for patients with stage IVB disease. In patients who received adjuvant therapy, OS was 30.1 months versus 4.7 months in patients who did not receive adjuvant therapy (P < 0.001). On multivariate analysis, only complete gross resection and the ability to receive adjuvant therapy were independently associated with OS.ConclusionsCytoreductive surgery, with a goal of achieving a complete gross resection, is associated with an improvement in OS among patients with advanced uterine CS.


► Only stage and residual disease are associated with survival in patients undergoing surgery for advanced uterine carcinosarcoma.
► Uterine risk factors do not influence survival in patients undergoing surgery for advanced uterine carcinosarcoma.
► Complete gross resection can be achieved without extensive surgical techniques.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gynecologic Oncology - Volume 123, Issue 3, December 2011, Pages 548–552
نویسندگان
, , , , , , , ,